# A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus

> **NCT00266461** · PHASE2 · COMPLETED · sponsor: **Tsumura USA** · enrollment: 24 (actual)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** Daikenchuto Extract Granules (TU-100)

## Key facts

- **NCT ID:** NCT00266461
- **Lead sponsor:** Tsumura USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00266461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00266461, "A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00266461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*